HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Denis Selected Research

Atherosclerosis

10/2019The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Denis Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
10/2013 - 01/2000
2Neoplasms (Cancer)
10/2013 - 07/2001
1Atopic Dermatitis (Atopic Eczema)
10/2019
1Eczema
10/2019
1Inflammation (Inflammations)
10/2019
1Pruritus (Itching)
10/2019
1Atherosclerosis
10/2019
1Chronic Disease (Chronic Diseases)
10/2013
1Diarrhea
07/2001
1Prostatic Intraepithelial Neoplasia
01/2000

Drug/Important Bio-Agent (IBA)

1gusacitinibIBA
10/2019
1Syk KinaseIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
10/2019
1E-SelectinIBA
10/2019
1Janus KinasesIBA
10/2019
1Tyrosine Kinase InhibitorsIBA
07/2001
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2001
1ErbB Receptors (EGF Receptor)IBA
07/2001
1Hormones (Hormone)IBA
01/2000
1AntigensIBA
01/2000

Therapy/Procedure

1Aftercare (After-Treatment)
10/2013
1Therapeutics
10/2013
1Nursing Care
10/2013
1Chemoprevention
01/2000